| Dr Laura Beth Wager, PHD, HSPP | |
|
403 Lark Ct Apt F, Carmel, IN 46032-1649 | |
| (317) 706-0353 | |
| Not Available |
| Full Name | Dr Laura Beth Wager |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 403 Lark Ct Apt F, Carmel, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346550647 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 20042456A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Laura Beth Wager, PHD, HSPP 403 Lark Ct Apt F, Carmel, IN 46032-1649 Ph: (317) 706-0353 | Dr Laura Beth Wager, PHD, HSPP 403 Lark Ct Apt F, Carmel, IN 46032-1649 Ph: (317) 706-0353 |
News Archive
Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today that it has started its phase II clinical study of a vaccine for primary prevention of Clostridium difficile infection (CDI). The trial starting in the United States is focused on evaluating prevention of the first episode of CDI in at-risk individuals, which includes adults with imminent hospitalization or current or impending residence in a long-term care or rehabilitation facility.
Scientists from Duke-NUS Medical School have derived a structural model of a transporter at the blood-brain barrier called Mfsd2a. This is the first molecular model of this critical transporter, and could prove important for the development of therapeutic agents that need to be delivered to the brain -- across the blood-brain barrier. In future, this could help treat neurological disorders such as glioblastoma.
​Cleveland Clinic, along with the National Cancer Institute, the University of Chicago and Thomas Jefferson University, are the recipients of a $600,000 Special Challenge Award from the Prostate Cancer Foundation (PCF) to investigate the role of abnormally high protein levels in prostate tumors.
Cellular Biomedicine Group, Inc., a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases, today announced that it has received approval to conduct a Phase IIb clinical trial for ReJoin, a human adipose-derived mesenchymal precursor cells (haMPC) therapy bio-engineered for Knee Osteoarthritis.
› Verified 1 days ago
Dr. Christine L. Gillies, PSY.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 12337 Hancock St Ste 20, Carmel, IN 46032 Phone: 317-706-6744 Fax: 317-706-6700 | |
Amy Louise Rexroth, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 230 1st St Ne, Carmel, IN 46032 Phone: 317-810-1005 | |
Dr. Kassandra Elizabeth Lowery, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 10291 N Meridian St Ste 310, Carmel, IN 46290 Phone: 176-721-9703 Fax: 317-672-1971 | |
Dr. Todd Steven Casbon, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 301 E Carmel Dr Ste D400, Carmel, IN 46032 Phone: 317-290-6738 | |
Dr. Anlize Korsts Salzman, PSYD, HSPP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 13295 Illinois St Ste 324, Carmel, IN 46032 Phone: 317-599-4501 | |
Amy M Mitchell, Psychologist Medicare: Medicare Enrolled Practice Location: 697 Pro-med Ln, Carmel, IN 46032 Phone: 317-587-0628 | |
Dr. Lindsay Ann Hallett Zimmerman, PSY.D., HSPP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 11350 N Meridian St Ste 300, Carmel, IN 46032 Phone: 317-660-1221 Fax: 317-660-6223 |